A Novel Non-Neuronal hSK3 Isoform with a Dominant-Negative Effect on hSK3 Currents

Cellular Physiology and Biochemistry

Volumn 14, Issue 1-2, 2004, Pages 23-30

  Wittekindt, Oliver H ^a,b   Dreker, Tobias ^a   Morris Rosendahl, Deborah J ^b   Lehmann Horn, Frank ^a   Grissmer, Stephan ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Alternative splicing; KCNN3; Potassium channel; SK3

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ION; POTASSIUM ION;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ARTICLE; CELL LINE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; EMBRYO; GENE LOCATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 1442352385     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076923     Document Type: Article

References (27)

1. Kohler M, Hirschberg B, Bond CT, Kinzie JM, Marrion NV, Maylie J, Adelman JP: Small-conductance, calcium-activated potassium channels from mammalian brain. Science 1996;273:1709-1714.
2. Fanger CM, Ghanshani S, Logsdon NJ, Rauer H, Kalman K, Zhou J, Beckingham K, Chandy KG, Cahalan MD, Aiyar J: Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. J Biol Chem 1999;274:5746-5754.
3. 2+ -activated potassium channels. J Neurosci 1999;19:8830-8838.
4. 2+ /calmodulin. Nature 2001;410:1120-1124.
5. Xia XM, Fakler B, Rivard A, Wayman G, Johnson-Pais T, Keen JE, Ishii T, Hirschberg B, Bond CT, Lutsenko S, Maylie J, Adelman JP: Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature 1998;395:503-507.
6. + currents in neurones: types, physiological roles and modulation. Trends Neurosci 1996;19:150-154.
7. Sah P, Louise Faber ES: Channels underlying neuronal calcium-activated potassium currents. Prog Neurobiol 2002;66:345-353.
8. Demolombe S, Baro I, Pereon Y, Bliek J, Mohammad-Panah R, Pollard H, Morid S, Mannens M, Wilde A, Barhanin J, Charpentier F, Escande D: A dominant negative isoform of the long QT syndrome 1 gene product. J Biol Chem 1998;20;273:6837-6843.
9. + channel hSK1 is affected by alternative splicing. Biochemistry 2001;40:3189-3195.
10. Shmukler BE, Bond CT, Wilhelm S, Bruening-Wright A, Maylie J, Adelman JP, Alper SL: Structure and complex transcription pattern of the mouse SK1 K(Ca) channel gene, KCNN1. Biochim Biophys Acta 2001;19;1518:36-46.
11. Tomita H, Shakotai VG, Gutman GA, Sun G, Bunney WE, Cahalan MD, Chandy KG, Gargus JJ: Novel truncated isoform of SK3 ptassium channel is a potent dominant-negative regulator of SK currents: implications in schizophrenia. Mol.Psychiatry 2003;8:524-535.
12. Wittekindt OH, Visan VM, Morris-Rosendahl DJ, Grissmer S: A scyllatoxin insensitve isoform of the human hSK3-channel. Biophysical Journal 2003;84:92a.
13. Heinzel SS, Krysan PJ, Calos MP, DuBridge RB: Use of simian virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells. J Virol 1988;62:3738-3746.
14. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP: Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987;7:379-387.
15. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ: Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100.
16. Grunnet M, Jespersen T, Angelo K, Frokjaer-Jensen C, Klaerke DA, Olesen SP, Jensen BS: Pharmacological modulation of SK3 channels. Neuropharmacology 2001;40:879-887.
17. Pereon Y, Demolombe S, Baro I, Drouin E, Charpentier F, Escande D: Differential expression of KvLQT1 isoforms across the human ventricular wall. Am J Physiol Heart Circ Physiol 2000;278:H1908-H1915.
18. Mohammad-Panah R, Demolombe S, Neyroud N, Guicheney P, Kyndt F, van den Hoff M, Baro I, Escande D: Mutations in a dominant-negative isoform correlate with phenotype in inherited cardiac arrhythmias. Am J Hum Genet 1999;64:1015-1023.
19. + channels in myotonic dystrophy. Muscle Nerve 1994;17:1264-1270.
20. Renaud JF, Desnuelle C, Schmid-Antomarchi H, Hugues M, Serratrice G, Lazdunski M: Expression of apamin receptor in muscles of patients with myotonic muscular dystrophy. Nature 1986;319:678-680.
21. Pribnow D, Johnson-Pais T, Bond CT, Keen J, Johnson RA, Janowsky A, Silvia C, Thayer M, Maylie J, Adelman JP: Skeletal muscle and small-conductance calcium-activated potassium channels. Muscle Nerve 1999;22:742-750.
22. Kimura T, Takahashi MP, Okuda Y, Kaido M, Fujimura H, Yanagihara T, Sakoda S: The expression of ion channel mRNAs in skeletal muscles from patients with myotonic muscular dystrophy. Neurosci Lett 2000;295:93-96.
23. + channel involved in the induction of myotonic-like characteristics. Cell Mol Neurobiol 1996;16:39-49.
24. + channel subunit, SK3. Science 2000;289:1942-1946.
25. Herrera GM, Pozo MJ, Zvara P, Petkov GV, Bond CT, Adelman JP, Nelson MT: Urinary bladder instability induced by selective suppression of the murine small conductance calcium-activated potassium (SK3) channel. J Physiol 2003;551:893-903.
26. + -channels suppresses EDHF-mediated vasodilation. Br J Pharmacol 2003;138:594-601.
27. + channels are expressed in pancreatic islets and regulate glucose responses. Diabetes 2003;52:2000-2006.